Clinical Trials Nct-pagina

Clinical Trial Results:
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV)

Summary
EudraCT number	2008-003600-55
Trial protocol	DE
Global completion date	12 Jun 2009

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?	No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?	No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?	No

Results information
Results version number	v1(current)
This version publication date	04 Jan 2017
First version publication date	04 Jan 2017
Other versions
Summary report(s)	CSR Synopsis - RSV01-106

Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.

Clinical Trials Nct-pagina

Clinical Trial Results:
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV)

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

Clinical Trials Nct-pagina

Clinical Trial Results: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV)

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

Clinical Trial Results:
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV)